Suzanne Fleming

Suzanne Fleming Chief Accounting Officer

Suzanne Fleming is Chief Accounting Officer at Beam Therapeutics. Ms. Fleming has more than 25 years of experience in finance leadership roles in the life science industry. Prior to joining Beam Therapeutics, Ms. Fleming served most recently as Senior Vice President, Finance and Treasurer at Epizyme, Inc., where she was responsible for all finance and accounting functions. Before Epizyme, she was Vice President, Finance at Foundation Medicine, where she worked closely with Roche after their purchase of a majority stake in the company. Ms. Fleming also held senior finance positions at Aegerion Pharmaceuticals, AVEO Pharmaceuticals, Transform Pharmaceuticals and Transkaryotic Therapies.

Ms. Fleming holds a B.S. degree in Accounting from Stonehill College and earned her CPA in Massachusetts.